Background The increasing number of patients treated by long-term non-invasive ventilation (NIV) challenges the capacity of ...
In hospitalized veterans with COVID-19, obstructive sleep apnea (OSA) was associated with greater use of non-invasive ventilation (NIV), but booster vaccination reduced this risk, a retrospective ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The available ...
Vivos Therapeutics, Inc. has announced the publication of positive results from a multicenter clinical trial on its Daytime-Nighttime Appliance (DNA) for treating obstructive sleep apnea (OSA) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results